Cita APA (7a ed.)

Liu, C. Y., Hong, Z., Dai, S., Sheth, S., & Shah, S. (2024). Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity. Wiley. https://doi.org/10.1111/ceo.14439

Cita Chicago Style (17a ed.)

Liu, Cindy Yue‐Ying, Zixin Hong, Shuan Dai, Shivanand Sheth, y Shaheen Shah. Bevacizumab Biosimilar (bevacizumab‐awwb) Is Safe in the Treatment of Retinopathy of Prematurity. Wiley, 2024. https://doi.org/10.1111/ceo.14439.

Cita MLA (9a ed.)

Liu, Cindy Yue‐Ying, et al. Bevacizumab Biosimilar (bevacizumab‐awwb) Is Safe in the Treatment of Retinopathy of Prematurity. Wiley, 2024. https://doi.org/10.1111/ceo.14439.